Healthcare and life sciences in Germany

Clifford Chance

Clifford Chance multidisciplinary global life sciences, healthcare & chemicals team, led by Peter Dieners and Ulrich Reese, is among the top addresses in Germany and offers comprehensive advice to its clients. The practice covers current developments in the healthcare sector, such as the use of AI, the increasing use and approval of digital healthcare apps including related data protection and reimbursement law matters, as well as topics pertaining to medical robotics, the development of fully integrated digital healthcare platforms and cyber attacks. Also active in the ever-growing healthcare technology area is Gunnar Sachs. The latter, Reese and Jörg Rhiel also assist with transactions, while Dieners is a key contact for compliance issues.

Praxisleiter:

Peter Dieners; Ulrich Reese


Weitere Kernanwälte:

Gunnar Sachs; Torsten Syrbe; Jörg Rhiel; Claudia Nawroth; Carolin Kemmner; Caroline Giesen; Yannick Frost


Referenzen

‘Covering almost all areas, experts for many different issues – everything from a single source.’

‘Good accessibility, high quality of advice.’

‘Gunnar Sachs is a very good lawyer in healthcare law and competition law.’

Highlight-Mandate


Hogan Lovells International LLP

Hogan Lovells International LLP is among the top players in the healthcare and life sciences sector and comprehensively advises on various topics with a focus on regulatory and contractual advice pertaining to future technologies in the life sciences sector, such as novel therapies and cell therapies – Jörg Schickert (co-head of the European regulatory team), Ina Brock (product liability), Arne Thiermann (regulatory, compliance) and Matthias Schweiger (litigation) frequently take the lead here. The team also covers issues at the interfaces with public law and contract law as well as IP, IT, data protection and product liability, thus advising on digital healthcare as well as strategic cooperations between pharmaceutical and IT companies. Schickert and Brock jointly head the practice with Andreas von Falck, who focuses on life sciences as well as the chemical and high-tech industries and represents clients in patent disputes, and Tanja Eisenblätter, who is particularly well versed in medical device and pharmaceutical advertising law. Lutz Angerer regularly advises large pharmaceutical companies and private equity houses on licensing and M&A transactions.

Praxisleiter:

Jörg Schickert; Tanja Eisenblätter; Andreas von Falck; Lutz Angerer; Ina Brock


Weitere Kernanwälte:

Arne Thiermann; Miriam Gundt; Matthias Schweiger


Referenzen

‘The team responds very quickly to inquiries. This means that smaller consultations in particular are carried out very promptly and quickly, which is extremely helpful and pleasant in everyday working life. The team’s specialist knowledge and expertise is convincing.’

‘Jörg Schickert is an outstanding lawyer who thoroughly analyzes problems in a very structured manner and quickly offers a suitable and practical solution.’

‘Arne Thiermann: I enjoy working with him. He is extremely reliable and quick and responsive to client needs.’

‘The firm has numerous lawyers with in-depth legal, technical and practical knowledge of the pharmaceutical industry.’

‘Internationally versatile team that already covers various jurisdictions within the firm and has an even larger network of partner law firms. This meant that a complex issue was assessed very quickly.’

‘Great competence and experience in the health sector and national legislation/case law, but also in-depth understanding of the relevant market with regard to international guidelines. Timely and careful work tailored to the needs of the company and the risk profile of the project. High availability and targeted communication.’

‘Jörg Schickert is very experienced and highly competent in all aspects of life sciences law, including regulatory, contractual and advertising law issues. He and his team support mandates in a timely, solution-oriented manner and with very good availability.’

Kernmandanten

Amylyx


Bundesverband Herzkranke Kinder e.V. (BVHK)


BMS


CatalYm


Chiesi Farmaceutici S.p.A.


Eli Lilly


Mirati Therapeutics


Regeneron


Roche Diagnostics


Highlight-Mandate


  • Advising Amylyx on market entry in Germany; Advice on pharmaceutical and pharmaceutical advertising law, the development of distribution systems, regulatory issues and the preparation of contracts.

  • Advising Roche Diagnostics in the area of ​​digital healthcare, including on data protection and regulatory aspects.

  • Advising numerous clients on criminal law issues, particularly in the area of ​​advertising law and product liability matters, such as product recalls.

Baker McKenzie

Baker McKenzie‘s advice comprehensively covers all healthcare and life sciences matters. The team is particularly well versed in regulatory and pharmaceutical law, here, practice head Thilo Räpple is a key contact; typical instructions pertain to regulatory compliance as well as physician, hospital, pharmacy and food law or pharmaceutical advertising law and social security matters. The pharmaceutical and healthcare technology industries are also increasingly advised on in the context of telemedical projects, while licensing matters are another growth area. Räpple is supported by Martin Altschwager (European and German pharmaceutical and medical device law, compliance, competition law issues in connection with healthcare products and services).

Praxisleiter:

Thilo Räpple


Weitere Kernanwälte:

Martin Altschwager; Frank Pflüger; Marc Gabriel


Referenzen

‘An incredibly high level of expertise and yet a focus on the essentials! It doesn’t get any better.’

‘The team is very consistent on a global level in terms of quality.’

‘Frank Pflueger is a responsive and extremely competent contact, who also handles the global coordination of all inquiries cost-effectively.’

Kernmandanten

Hexal AG


Highlight-Mandate


  • Advising international pharmaceutical companies and leading pharmaceutical industry associations on security of supply in pharmaceutical discount agreements and the privileging of EU production sites.

  • Advising and representing international and German pharmaceutical companies in defending against contractual penalty and damages claims from statutory health insurance companies due to delivery failures when implementing drug discount contracts with disputed amounts totaling several million euros.

  • Advising global pharmaceutical companies and leading pharmaceutical industry associations in the context of several projects that were at the interface with various legislative proposals at the federal level and found their way into federal politics.

CMS

CMS assists medical device manufacturers, biotechnology companies, food and cosmetics manufacturers, start-ups, service companies, hospitals and pharmacies as well as players in the research-based pharmaceutical industry. The dirverse client roster benefits from cross-practice cooperation. The practice advises on regulatory and licensing matters – including recent cooperations between manufacturers of pharmaceuticals and medical devices – as well as on medicinal cannabis, transactions and digital healthcare topics, including related data protection issues. This is complemented by capacities in contentious topics under competition and pharmaceutical advertising law. Jens Wagner (pharmaceuticals, biotechnology, medical devices and dietary supplements as well as IP) heads the team from Hamburg.

Praxisleiter:

Jens Wagner


Weitere Kernanwälte:

Jörn Witt; Roland Wiring; Matthias Eck; Heike Blank


Referenzen

‘CMS advises us at various locations and in numerous legal areas and is one of our most important external legal advisors.’

‘What we particularly appreciate about CMS is the pragmatic and practice-oriented approach, the service orientation, the very high professional quality and the distinctive industry expertise.’

‘The Life Sciences team in Hamburg with Jens Wagner as lead partner is our central contact for all questions and topics relating to medical devices.’

Kernmandanten

Bayer AG


Bloomwell Group


Boehringer Ingelheim Pharma


Corteva Agriscience


Eli Lilly and Company


GE Healthcare


Johnson & Johnson


MSD


Nordmark


Synlab


Highlight-Mandate


  • Advising GE Healthcare on the AMNOG benefit assessment following the new approval of a drug, and representing it in landmark proceedings before the Federal Social Court.

  • Regulatory, contractual and compliance advice to the Bloomwell Group on structuring the business model for the telemedicine, wholesale and online mail order branches for medicinal cannabis.

  • Advising and representing PharmaEssentia Corporation in a dispute arising from a license agreement with an Austrian pharmaceutical company.

Covington & Burling LLP

Covington & Burling LLP's life sciences team is based in Frankfurt and led by pharmaceutical and medical device law specialist Adem Koyuncu, who is dually qualified as physician and lawyer. The team offers a cross-location approach and regularly advises start-ups as well as leading national and international companies in the pharmaceutical, biotechnology, diagnostics, medical technology, cosmetics and food industries. Among the key topics are transactions and internal investigations as well as regulatory matters, including pharmaceutical and medical device law, and compliance. The group frequently cooperates with the Brussels location on European issues, such as EU medical device law; interfacing data protection matters are also covered.

Praxisleiter:

Adem Koyuncu


Referenzen

‘Adem Koyuncu’s qualifications as both a lawyer and a doctor enable a specialist discussion on a spectrum that is second to none. In discussions with medical key opinion leaders, his qualifications as a doctor and as a member of an ethics committee mean that he has a completely different level of acceptance than is usually the case. This also means he can explain legal aspects much better to doctors.’

Kernmandanten

BioNTech SE


JenaValve Technology GmbH


CONET GmbH


EFPIA – Verband


MedTech Europe & EFPIA


Highlight-Mandate


  • Ongoing advice to the EFPIA association on various pharmaceutical law and data protection issues as well as on legal and strategic questions regarding GDPR implementation.

  • Advising a US manufacturer of medical devices on numerous clinical studies, data protection and regulatory matters, as well as on the introduction of an app and cloud-based services; also advice on medicinal advertising and medical device law.

  • Advising the European medical device association MedTech Europe and the pharmaceutical association EFPIA on the draft regulation on the European Health Data Space (EHDS).

D+B Rechtsanwälte Partnerschaft mbB

Boutique D+B Rechtsanwälte Partnerschaft mbB comprehensively advises on healthcare matters and focuses on statutory health insurance. The diverse client roster includes pharmaceutical and medical technology companies, pharmacies, physicians, hospitals, authorities and federal ministries. The firm fields a pharmaceuticals and pharmacy team led by Ulrich Grau and Constanze Püschel, a physician contract law group led by Martin Stellpflug and Thomas Willaschek and a hospital team headed by Thomas Bohle and Christian Reuther, thereby advising clients across practices, including the support in regulatory matters and interfacing data protection, advertising and criminal law issues. Digital healthcare is a recent growth area, which is also supported with a cross-practice approach, a key contact here is Christian Pinnow (in addition to physician contract and psychotherapist legislation as well as medical care centers). Jan Moeck (physician contract law and psychotherapist legislation) and Tobias Volkwein (pharmaceutical law, medical device law, statutory health insurance) are also part of the core team.

Praxisleiter:

Ulrich Grau; Thomas Bohle; Martin Stellpflug; Constanze Püschel; Thomas Willaschek; Christian Reuther; Jan Moeck; Christian Pinnow; Tobias Volkwein


Weitere Kernanwälte:

Christina Deckers


Referenzen

‘D+B focuses on service providers and can pool its resources in this segment. This benefits the clients through competence and up-to-dateness.’

‘Thomas Bohle has a high level of professional expertise and can explain even complex issues to his clients in a comprehensible manner. We particularly appreciate his realistic assessment of the facts and prospects of legal disputes. We have been successful with him in each of our cases so far.’

‘D+B is characterized by outstanding expertise in the entire area of ​​medical law. What is particularly pleasant is the close integration of the various legal areas (including pharmaceutical, medical device, pharmacy, contract doctor and hospital law). This means that even complex legal questions get answered quickly and comprehensively.’

‘I recommend the team around Dr. Thomas Willaschek, which is characterized by its excellent technical skills as well as a very dynamic and service-oriented approach.’

‘What is worth mentioning and particularly pleasing from a client perspective is the focus, among others, of Thomas Willaschek in the area of ​​digital health, which is constantly being further developed.’

‘Unique expertise in questions relating to healthcare and excellent contacts to decision-makers in politics and self-administration.’

‘Ulrich Grau: Comprehensive expertise in all important areas of the healthcare system. Excellent individual assessments and a high success rate in all disputes are a trademark of the entire firm, but especially of Dr. Gray.’

‘Dr. Constanze Püschel: Fast response times, good availability, high level of professional expertise.’

Highlight-Mandate


  • Advising Helios Health GmbH in the regulatory area on innovative digital health projects.

  • Regulatory advice to ro club GmbH on the design of the business model for teleoperations in the healthcare sector.

  • Advising Astra Zeneca on regulatory issues, including the market launch of a new drug.

Gleiss Lutz

Gleiss Lutz focuses on advising health insurance companies on patients rights, social security, regulatory and medical law, while the team is also increasingly being instructed by medical technology and pharmaceutical companies. Other growth areas include healthcare compliance and transactions. Clients' representation, including mass proceedings, is another mainstay of the practice; here, the practice frequently advises on claims for damages in the context of vaccine-related injuries. This is complemented by expertise in the areas of medicinal cannabis, data protection and digitisation as well as procurement and patent law. The interdisciplinary team is jointly led by Reimar Buchner (statutory health insurance, hospital, pharmaceutical and physician law) and Martin Viciano Gofferje (transactions and joint ventures).

Praxisleiter:

Martin Viciano Gofferje; Reimar Buchner


Weitere Kernanwälte:

Marco König; Enno Burk; Eike Bicker; Andreas Neun; Christian Hamann


Referenzen

‘Extremely competent and client-oriented approach at eye level.’

‘Excellent law firm for the pharmaceutical industry and the healthcare sector in general.’

‘Marco König is an absolute expert in his field and is very well supported by his team.’

Kernmandanten

AOKen (Bundesverband, Landesverbände)


Bundesministerium für Gesundheit


Paracelsus Kliniken


Klinikum Lippe


Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)


Curaleaf Holdings, Inc., Vereinigte Staaten von Amerika


Paul Ehrlich Institut


Carl Zeiss Meditec AG


Fraunhofer


MAYD Group GmbH


Roche


Verband der Ersatzkassen e.V. (vdek e.V.)


EuC Management Pty. Ltd


Dr. Sennewald Medizintechnik


Highlight-Mandate


  • Advising Curaleaf Holdings, Inc. on the acquisition of a 55% stake in Four 20 Pharma GmbH, a fully EU GMP and GDP licensed German manufacturer and wholesaler of medicinal cannabis.

  • Advising EuC Management Pty. Ltd on the market entry of the telemedicine portal Eucalyptus, which specializes in obesity.

  • Supporting MAYD Group GmbH before various federal state pharmacy supervisory authorities on the legality of the business model, in competition law proceedings as well as in correspondence and evaluation with investors.

Hengeler Mueller

Hengeler Mueller‘s healthcare team cooperates across practices, thus comprehensively covers interfacing matters. Dirk Uwer has expertise in white-collar criminal law and is regularly instructed in connection with internal investigations. Administrative and regulatory expert Wolfgang Spoerr is experienced in contentious proceedings before the relevant authorities, courts and arbitration tribunals; he is also well versed in regulatory matters, including medical device law and interfacing data protection matters, as well as the implementation of compliance management systems. Counsel Susanne Koch is experienced in pharmaceutical law and transaction support, while counsel Erasmus Hoffmann is another key contact and covers the interface between healthcare, data protection and product compliance.

Praxisleiter:

Dirk Uwer; Wolfgang Spoerr; Susanne Koch; Erasmus Hoffmann


Weitere Kernanwälte:

Alexander Nolte


Highlight-Mandate


Latham & Watkins LLP

Latham & Watkins LLP's focus in the healthcare and life sciences sector is on transaction support, where the team is regularly instructed by financial investors and industrial companies. A key strength is the support in US-related transactions, thanks to the close cooperation with the respective locations . The team is led by transaction experts Henning Schneider and Christoph Engeler; the latter also advises on regulatory issues. Associate Henrietta Ditzen is another key contact and assists with transactions and regulatory issues, thereby underlining the overall approach.

Praxisleiter:

Henning Schneider; Christoph Engeler


Weitere Kernanwälte:

Henrietta Ditzen


Highlight-Mandate


McDermott Will & Emery Rechtsanwälte Steuerberater LLP

McDermott Will & Emery Rechtsanwälte Steuerberater LLP‘s advisory offering focuses on three segments: project support (transactions and cooperations), regulation (market entry and licensing) and digitisation. The latter frequently pertains to the development of healthcare apps and databases, including interfacing data protection matters, a key contact here is Deniz Tschammler. Among the client roster are pharmaceutical, medical technology and biotechnology companies; the advice to healthcare funds on transactions and venture capital financing is a recent growth area. Practice head Stephan Rau specialises in M&A transactions as well as regulatory and compliance issues. He is supported by Monika Emilia Richter (implementation and advice on strategic cooperations, licensing, development agreements) and Jana Grieb, who advises pharmaceutical and medical technology companies on various issues, including research and development-related issues as well as market entry, advertising and sales. M&A expert Nadine Hartung joined Raue in March 2023.

Praxisleiter:

Stephan Rau


Weitere Kernanwälte:

Deniz Tschammler; Monika Richter; Jana Grieb; Lea Hachmeister


Referenzen

‘Technical expertise, efficiency, project knowledge, customer knowledge, international network and years of trusting cooperation in all areas.’

‘I have been working with Stefan Rau for years – excellent lawyer in the areas of statutory health insurance and corporate law. Perfect and always available, very flexible, sharp thinking, very good connections in related legal areas. Last but not least – very good team around the lawyer.’

‘Communication always takes place with the main contact. If needed, internal addition of lawyers who may have particular knowledge in related areas of law. Processing is very quick, communication is uncomplicated and project development is very good. The responsiveness of the key contacts is also very good.’

‘McDermott’s life sciences practice is a beacon of excellence in the legal landscape. What sets them apart is not only their specialist knowledge, but also their reliability. One can always count on McDermott to deliver results that are not only legally sound, but also strategically aligned with company goals.’

‘Monika Richter is an outstanding personality in the legal world. Her extensive knowledge of the life sciences is remarkable. Monika Richter’s ability to translate complex legal concepts into actionable insights has proven time and time again to be invaluable. What really sets Monika apart, however, is her reliability. Her commitment goes beyond the usual legal advice; she takes the time to understand the unique needs of our business and delivers tailored solutions that meet both legal requirements and business objectives.’

‘Monika Richter’s responsiveness and clear communication created a trusting environment in which we felt supported and understood at every stage of the legal process.’

‘Highly competent representation of our positions. Very focused and clear implementation of the mandate.’

‘Outstanding commitment; pragmatic approach; efficient solutions and pleasant handling by Dr. Deniz Tschammler.’

Kernmandanten

Amalgam RX


AUCTUS Capital Partners AG


AXA Konzern AG


Bundesverband der Betreiber medizinische Versorgungszentren


Centric Health Holdings Ltd


Dentsply Sirona


GlaxoSmithKline GmbH & Co. KG


GREENPEAK Partners Advisory GmbH


lifespin GmbH


Myonex Inc


Merck KGaA


PharmaLex GmbH


Ryvu Therapeutics S.A.


Santen SA / Santen GmbH


STADA Arzneimittel AG


Highlight-Mandate


NOVACOS Rechtsanwälte

Healthcare boutique NOVACOS Rechtsanwälte comprehensively advises national and international clients in the healthcare, biotechnology, pharmaceutical and chemical sectors, including regulatory issues, market entry and reimbursement as well as product safety and compliance. Another core area of ​​the team is drafting healthcare-related contracts, Maria Heil is a key contact here, the practice also represents clients before the relevant courts and authorities. Christian Stallberg is experienced in matters pertaining to pharmaceuticals, medical devices, cosmetics and chemicals, including pesticides and biocides. Clients also benefit from the team's expertise in healthcare-related digitisation matters, such as  healthcare data protection, procurement law and issues pertaining to the e-health sector. Christian Hübner is well versed in pharmaceutical and pharmaceutical advertising and also focuses on transaction and cooperation support.

Weitere Kernanwälte:

Maria Heil; Alexander Natz; Marc Oeben; Christian Hübner; Christian Stallberg


Referenzen

‘High level of technical expertise and political flair.’

‘Christian Hübner is very experienced, well informed, thinks outside the box and has the client’s perspective in mind.’

‘Christian Hübner: Sound, targeted advice, he becomes part of the team and thinks for the client, he doesn’t just advise from the outside.’

Kernmandanten

Rhythm Pharmaceuticals


Ultragenyx


Highlight-Mandate


  • Advising Nordic Capital on the acquisition of corpuls – GS Elektromedizin Geräte G. Stemple GmbH, manufacturer of defibrillators and provider of telemonitoring services.

  • Advising Rhythm Pharmaceuticals on all questions relating to the statutory health insurance system, including the AMNOG procedure and lifestyle medicines.

  • Advising Ultragenyx on market access in Germany.

Taylor Wessing

Taylor Wessing's focus is mirrored in the practice group management: Anja Lunze heads the life sciences segment, while Michael Stein is the key contact for the healthcare sector. Clients benefit from the close cooperation of the corporate, M&A and regulatory teams, where the team regularly supports buyers in transactions in the outpatient and inpatient sectors and in the formation of groups of medical care centers; the team also covers the procurement law interface, including advising hospital chains on the Hospital Future Act and the implementation of IT system, above all, hospital information systems. The focus in the life sciences area is on advising pharmaceutical and biotechnology companies on medical, pharmaceutical, patent and trademark law issues, including product liability and contentious matters. This is completed by capacities in the digital healthcare segment, where the regulatory team frequently cooperates with the TMT practice. Medical law expert Karolina Lange-Kulmann was appointed partner in April 2023, while Stefanie Greifeneder (regulatory, commercial and contract-related matters in the pharmaceutical, medical device and biotechnology sectors; compliance) joined the team the following month from Fieldfisher.

Praxisleiter:

Anja Lunze; Michael Stein


Weitere Kernanwälte:

Karolina Lange-Kulmann; Stefanie Greifeneder; Daniel Tietjen


Referenzen

‘The Taylor Wessing team has always been very responsive, well prepared and extremely professional.’

‘Collaboration is always fair and based on transparency and a high level of accuracy.’

‘We are impressed by the team’s integrated approach and deep industry know-how. Inquiries are answered quickly, competently and practically. The understanding of the problem, shaped by years of industry experience, and the creativity in problem solving are convincing.’

‘The practice has an extremely high level of competence in all areas. This means that complex issues that do not just affect one regulatory area are dealt with in an interdisciplinary and holistic manner.’

‘Daniel Tietjen has excellent knowledge of competition law, particularly pharmaceutical advertising law, and regularly supports us in this area. I really appreciate the practical but also creative solutions.’

‘The team offers uncomplicated, expert support at all times.’

‘Daniel Tietjen always responds quickly, works very conscientiously and is always very solution-oriented.’

‘Hands-on and strong in teamwork on interdisciplinary cases.’

Kernmandanten

Amedes


AstraZeneca


Azenta INC


Bayer


Cochlear


Daiichi Sankyo


Dana-Faber Cancer Institute


Fresenius Kabi Swiss BioSim


Morphosys


MTK Pharma


NORD Holding


Oberberg


Pfizer


Sanecum


STADA Arzneimittel


Viatris


Highlight-Mandate


  • Advising numerous financial investors and their portfolio companies (including amedes, NORD Holding, Oberberg, Sanecum and Trilantic) on various transactions in the inpatient and outpatient sectors, particularly with regard to the implementation of their respective buy-and-build strategies.

  • Defending AstraZeneca against consumer lawsuits regarding its Covid-19 vaccine.

  • Representing Pfizer in the patent infringement proceedings brought by Moderna regarding the alleged infringement of mRNA vaccine patents (Comirnaty).

Allen & Overy LLP

Allen & Overy LLP follows an interdisciplinary and cross-border approach and advises a diverse client base consisting of pharmaceutical and biotechnology companies, medical technology and diagnostics providers as well as investors and financial services providers. Practice head Alexander Veith is experienced in transaction support; he is supported by counsel Eda Zhuleku, who is well versed pan-European regulatory matters. The latter include the advice on cloud-based digital healthcare platforms in medicine and telemedicine and on healthcare apps as well as reimbursement issues pertaining to medicines. Further competencies are assisting new companies with market entry in the in-vitro diagnostics area as well as supporting health incurance companies in contract-related matters; clients are also represented in patent disputes.

Praxisleiter:

Alexander Veith


Weitere Kernanwälte:

Eda Zhuleku; Stephan Neuhaus; Hartmut Krause


Referenzen

‘Very well managed team. Quick processing of inquiries at the highest professional level.’

‘Very good collaboration with Eda Zhuleku. She works very quickly and very professionally and always offers very good, practical solutions.’

‘Such perfect cross-functional collaboration within a large law firm is rare. Super fast coordination between the individual areas and the answers, recommendations and elaborations are concise, pragmatic and to the point. Just the way you want it to be as an in-house counsel.’

Kernmandanten

Kyowa Kirin International (KKI)


Novo Nordisk A/S


Carl Zeiss Meditec AG


Bayer AG


Organon


Johnson & Johnson


Enovis Corporation


Santhera Pharmaceuticals Holding AG


Vision Healthcare B.V.


VetFamily GmbH


Sleepiz AG


Inotiv


Colosseum AG


DOKTOR SE NORDIC AB


Highlight-Mandate


  • Advising Kyowa Kirin International on its joint venture collaboration with Grünenthal regarding KKI’s established drug portfolio.

  • Advising Bayer AG on the sale of its men’s health product Nebido™ (testosterone undecanoate) to Grünenthal. The transaction volume totals up to €500 million.

  • Advising Novo Nordisk A/S on the coordination of its pan-European patent dispute regarding Novo Nordisk’s Victoza®/Saxenda® products.

Bird & Bird

Bird & Bird's healthcare expertise includes capacities at the interfaces with IP, procurement law and digitisation as well as contentious issues. Dispute resolution in the life sciences sector is a focus area of the team, which is led by Boris Kreye; Kreye regularly assists with patent infringement disputes in connection with medical devices. Alexander Csaki advises private companies and public sector clients at the interface between procurement and regulatory law, including the advice on selective contracts issued by statutory health insurance companies as well as licensing matters, the interchangeability of drugs and drug prices.

Praxisleiter:

Boris Kreye


Weitere Kernanwälte:

Alexander Csaki


Dentons

Dentons is led by Christof Kautzsch and comprehensively advises innovative pharmaceutical manufacturers, hospital groups, health insurance companies as well as companies from the medical device, pharmaceutical, biotechnology and diagnostics sectors, financial investors and research institutions. The practice closely cooperates with other locations as well as with the corporate, M&A, procurement and employment law teams, thereby covering regulatory issues. Kautzsch offers transaction support, while Ilka Mehdorn is well versed in regulatory issues and Peter Homberg advises on matters pertaining to medicinal cannabis. Matters at the interfaces with IP and IT are also covered, where the team represents pharmaceutical companies in trademark and patent disputes as well as in civil and criminal law proceedings in connection with pharmaceutical crime. Homberg also advises on cross-border IP licences, commercial contracts and transactions, he is supported by senior associate Malte Goetz.

Praxisleiter:

Christof Kautzsch


Weitere Kernanwälte:

Peter Homberg; Ilka Mehdorn; Thomas Strassner; Malte Goetz


Kernmandanten

atai Life Sciences


BARMER


Bayer AG


BG Kliniken Ludwigshafen und Tübingen gGmbH / BG Kliniken – Klinikverbund der gesetzlichen Unfallversicherung gGmbH


CherryHUB


DEMECAN GmbH


GH Research


HiDoc Technologies


Jeito Life & Brandon Capital


Klinikum Darmstadt


Novartis AG


numares AG


Roche Diagnostics GmbH


Roche Pharma AG und RoX GmbH


Sana Klinik Service GmbH


Schnorrenberg Chirurgiemechanik GmbH (umfirmiert in Medworx GmbH)


Highlight-Mandate


  • Advising DEMECAN GmbH on the preparation of a legal opinion on the possibility of legalizing cannabis for recreational purposes in Germany as well as on the legal requirements for a scientific cannabis model project in Germany.

  • Advising a company in the field of digital health on a cooperation agreement with large pharmaceutical companies to develop a better and digitalized healthcare system in Germany. Regulatory and data protection analysis of a concept regarding the development of a project for the processing of raw patient data and their usability in the context of clinical studies.

  • Advising Jeito Life & Brandon Capital on the € 50 million Series C financing for the biotech company CatalYm GmbH.

Dierks+Company

Dierks+Company is led by the pharmaceutical and medical device law experts and general practitioner Christian Dierks. The practice follows an intergrated and interdisciplinary approach, whereas project management and healthcare-related IT matters are also covered. The team increasingly advises at the interface with ​​public matters, which leads to frequent instructions in the context of legislative proposals. This is complemented by expertise in the development and establishment of innovative products as well as digital healthcare services, including data protection issues. Steffen Schröder is a key contact for matters pertaining to the global distribution of medicines as well as the research and development of medicines and their international licensing. In October 2023, counsel Katrin Helle (regulatory law) joined the team at White & Case LLP, while Dominik Roters, general counsel and deputy managing director of the Federal Joint Committee (G-BA), joined the team in January 2024; he is experienced in advising on pharmaceuticals and statutory health insurance.

Praxisleiter:

Christian Dierks


Weitere Kernanwälte:

Ulrike Knirsch; Steffen Schröder; Dominik Roters


Referenzen

‘Very experienced teams – always with the correct breadth and depth in the requested topics – top!’

‘Our experiences have been positive all around, response times are quick and the service overall is very positive.’

‘Both Christian Dierks and his secretary and assistant are reliable; Competence in discussions and developing solutions. Deadlines will be adhered to.’

Kernmandanten

Aignostics GmbH


Alexion Pharma Germany GmbH


Alnylam Pharmaceuticals


Angelini Pharma


Apotheke im Elisenpalais


Bencard Allergie


BVDD


Brainlab


Bundesministerium für Gesundheit (BMG)


Bundesverband der Pharmazeutischen Industrie e.v. (BPI)


Burg Pharma


Bundesverband Medizintechnologie e. V.


Cerus Corporation


Cord Blood Center


DIERS International GmbH


DMI


DocMorris


epitop GmbH


Esper Bionics


EuMelaReg


Flatiron Health Inc


Gesundes Kinzigtal GmbH


GHD GesundHeits GmbH Deutschland


GOREHA


“HIT” (HEALTHCARE IT-Solutions GmbH)


HiDoc


Johnson & Johnson


Kenbi GmbH


Kaufmännische Krankenkasse – KKH


Krystal Biotech


Labor Becker


Labor Berlin


Medevice – Medizinische Geräte GmbH


Medgate


Medios AG


MedTech Europe


medudy


Mehiläinen


MindPeak


MiProbes


Mirati Therapeutics


Merck Sharp & Dohme


Ocumeda AG


Oncosil


Oviva


Pfizer Pharma GmbH


Retrobrain R&D


RR Technologies


Samsung Electronics GmbH


Santen Pharmaceutical


Sedana Medical


SHL Telemedizin


Sympatient


Therakos (UK) Ltd


Universitätsklinikum Essen


Universitätsklinikum Tübingen


Vision Zero


Vivira Health Lab GmbH


XO Life


Zambon GmbH


Zur Rose Group


Highlight-Mandate


  • Support for change4RARE in the initiative of the same name, through which knowledge about the care of rare diseases is bundled with the active involvement of various specialist disciplines and perspectives and made accessible to an interested (professional) public; Advice, among other things, on the design of the initiative as well as the content and structural development; In addition, strategic support of the communication campaign.

  • Support in setting up the NUM (National Network for University Medicine), including all essential contracts and data protection documents.

  • Support for the EHDS coalition project in the development of position papers, formulation aids, reports and concepts for the communicative support of these products in political and legislative processes for the design of the EHDS regulation.

Friedrich Graf von Westphalen & Partner

Led by the pharmacy law expert Morton Douglas and the commercial and corporate law specialist Jan Henning Martens, Friedrich Graf von Westphalen & Partner supports large pharmaceutical companies, biotechnology start-ups, medical device manufacturers, pharmacies, laboratories, hospitals and care facilities in all matters under health law. Interfacing corporate law and M&A matters are frequently covered by Hendrik Thies and Meike Kapp-Schwoerer, while Sabine Schröter handles the interface with employment law, including reorganisations. The team is also experienced in model proceedings pertaining to pharmacy law as well as pharmaceutical advertising law.

Praxisleiter:

Jan Henning Martens; Morton Douglas


Weitere Kernanwälte:

Hendrik Thies; Sabine Schröter; Meike Kapp-Schwoerer


Referenzen

‘Dr. Sabine Schröter: The expertise goes far beyond her specialist area, as she also has an outstanding wealth of experience in business and economics.’

Kernmandanten

APO Pharma Immun GmbH


Apothekerkammer Nordrhein


Bentley InnoMed GmbH


Deutsche Fach-pflege Gruppe Holding GmbH


Dr. Langer Medical GmbH


Dt. Versandapotheke Fliegende Pillen


Essilor International S.A.


Getinge-Gruppe


Lenus GmbH


Paracelsus Kliniken Deutschland GmbH & Co. KGaA


Petenten


Pulsion Medical Systems S E


RED Medical Systems GmbH


Tillotts Pharma AG


VDARZ – Bundesverband Deutscher Apothekenrechenzentren


Highlight-Mandate


  • Ongoing advice to the North Rhine Association of Pharmacists on numerous model proceedings before German and European courts.

  • Advising Bentley InnoMed GmbH on the MedTech deal with Upstream Peripheral Technologies.

  • Advising the shareholders of Dr. Langer Medical GmbH on the sale of the company to Brainlab AG.

King & Spalding LLP

King & Spalding LLP focuses on regulatory advice in the life sciences sector at the interfaces with food, pharmaceutical and medical device law, which leads to frequent instructions pertaining to product launches, market entry and recalls as well as compliance. The team also represents clients in competition law proceedings, such as parallel import proceedings. This expertise is evident in a recently obtained groundbreaking judgment for the pharmaceutical market, where practice head Ulf Grundmann took the lead. Counsel Elisabeth Kohoutek complements this with experience in M&A transactions, here, the practice regularly cooperate with the international network.

Praxisleiter:

Ulf Grundmann


Weitere Kernanwälte:

Elisabeth Kohoutek


Referenzen

‘King & Spalding is one of the leading law firms for parallel trade cases and trademarks in the pharmaceutical industry. They have represented various pharmaceutical companies at all judicial levels, including before the Court of Justice of the European Union.’

‘King & Spalding has deep expertise in trademark law for the pharmaceutical industry.’

‘Ulf Grundmann is very experienced. What sets him apart is his ability to think outside the box – his legal strategies are very creative yet highly effective.’

Kernmandanten

Novartis Pharma AG


ratiopharm GmbH


GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare


biomo Group


Angelini Pharma Deutschland GmbH


Teva Pharmaceuticals Europe B.V. und Teva GmbH


Dr. Willmar Schwabe GmbH & Co. KG


Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)


Roche Diagnostics


Chemische Fabrik Kreussler Co. GmbH


DR. KADE Pharmazeutische Fabrik GmbH


Diagnostic Green


SGF International e.V.


Eckes-Granini Group


Heilerde-Gesellschaft Luvos Just GmbH & Co. KG


MODJAW SAS


AgNovos Healthcare


Highlight-Mandate


  • Representation of Novartis Pharma AG as the original manufacturer in the submission procedure before the ECJ regarding the parallel import of pharmaceuticals.
     

  • Advising GSK Consumer Healthcare in a competition dispute regarding advertising claims for the Vitasprint Pro Immun product.

  • Advising the French medical technology company MODJAW SAS in a competition dispute against zebris GmbH in connection with a medical device and its classification as a medical device.

Linklaters

Linklaters' healthcare team is integrated into the global healthcare and life sciences group, thus covers cross-border matters, including transactions, restructuring and joint ventures. The practice is led by Jana Hager, who joined the partner roster in May 2023. Clients stem from the pharmaceutical, biotechnology, medical devices and healthcare services sectors and frequently instruct the team on interfacing corporate and M&A matters as well as regulatory issues in the area of ​​product liability and safety, including related disputes, as well as ​​compliance. Bolko Ehlgen and Julia Schönbohm both complement this offering with expertise in patent law as well as in the digital healthcare and data protection segments.

Praxisleiter:

Jana Hager


Weitere Kernanwälte:

Bolko Ehlgen; Julia Schönbohm


Highlight-Mandate


  • Advising GlaxoSmithKline in a tender process for the award of a so-called pandemic preparedness contract, including negotiations with the Federal Republic of Germany, as well as advising on negotiations with the consortium partner CureVac. Additionally, advice on liability and exemption clauses in the pandemic preparedness contract.

  • Advice to Carlyle and PAI Partners on the acquisition of Theramex, including regulatory advice relating to the investigation of regulatory compliance and product risks and the related contractual drafting.

  • Advising Fresenius SE & Co. KGaA and its committees on the deconsolidation of its subsidiary Fresenius Medical Care AG & Co. KGaA by means of a change of legal form into a stock corporation.

Luther Rechtsanwaltsgesellschaft mbH

Led by Oliver Kairies (Hannover), of counsel Cornelia Yzer (Berlin) and Denis Ullrich (Leipzig), Luther Rechtsanwaltsgesellschaft mbH 's healthcare and life sciences team offers cross-practice advice on transactions (above all in the hospital sector) and the market launch of medical devices (where the team frequently assists pharmaceutical and medical device manufacturers with related regulatory matters) as well as distribution law and product liability. The digital healthcare segment includes expertise in IT, IP and data protection, which leads to regular instructions by foreign investors in the context of smart healthcare solutions; traditional medical device manufacturers are also among the client roster.

Praxisleiter:

Oliver Karies; Cornelia Yzer; Denis Ullrich


Weitere Kernanwälte:

Thomas Gohrke; Eva-Maria Rütz; Hendrik Bernd Sehy


Referenzen

‘Quick response times and appointment scheduling for coordination.’

Kernmandanten

IDT Biologika GmbH


CHUGAI PHARMA EUROPE LIMITED


ZytoService Beta GmbH


Mehiläinen Oy


DELABO.GROUP GmbH


Ottobock MedicalCare GmbH


Land Brandenburg


Landkreis Oberspreewald-Lausitz


Städtisches Klinikum Braunschweig gGmbH


Klinikum Niederlausitz GmbH


Stadt Köln


Universitätsmedizin Göttingen


Medizinische Hochschule Hannover


Universität Siegen


Verwaltungs-Berufsgenossenschaft (VBG) gesetzliche Unfallversicherung


Highlight-Mandate


  • Advising Mehiläinen Oy on the acquisition of an MVZ chain.

  • Advising the state of Brandenburg on the development of the Lausitz model for a new type of university medicine.

  • Legal and tax advice to QIMA Ltd. on the acquisition of 100% of the shares in MONASTERIUM LABORATORY – Skin & Hair Research Solutions GmbH.

Meisterernst Rechtsanwälte

Meisterernst Rechtsanwälte places a dual focus on pharmaceutical and food law and advises clients from the pharmaceutical and medical device sectors on competition law and pharmaceutical advertising law issues, including litigation. The latter also includes landmark proceedings, where practice head Christian Tillmanns frequently takes the lead. Recent instructions include advising pharmaceutical companies on price negotiations and cost-benefit assessments. Markus Fuderer was appointed partner in January 2023; he is well versed in matters pertaining to technology, including software solutions and AI, as well as cybersecurity and data protection.

Praxisleiter:

Christian Tillmanns


Weitere Kernanwälte:

Sylvia Braun; Markus Fuderer


Referenzen

‘Dr. Christian Tillmanns and Sylvia Braun represented us extremely competently and successfully in and out of court.’

‘In addition to the advertising law and procedural expertise and experience of the team led by Dr. Christian Tillmann’s breadth of consulting practice should also be emphasized.’

‘The advice is characterized in particular by the extensive experience, high level of professional expertise, great pragmatism and targeted focus. Particularly noteworthy are the tactical skills and the great competence and experience in competitive processes.’

‘The client focus and pragmatism combined with high professional quality are still particularly praiseworthy.’

‘The team works at a high academic level, statements in the written submissions are supported by numerous references. The collaboration is pragmatic, solution and goal-oriented and very collegial.’

‘Christian Tillmanns is an extremely sociable and reliable partner whose word one can rely on. He is very experienced.’

‘Deep knowledge of pharmaceutical advertising law, great litigators!’

‘Team is technically experienced in all questions relating to pharmaceutical, medical device and pharmaceutical advertising law as well as in related areas.’

Kernmandanten

Alnylam Germany GmbH / Alnylam Switzerland GmbH


Amicus Therpeutics GmbH


Lifescan Deutschland GmbH


Queisser Pharma GmbH & Co. KG


Salus Haus Otto Greither GmbH & Co. KG


Highlight-Mandate


  • Supporting the preparation of the market entry of new products for the biopharmaceutical company Alnylam, headquartered in the USA; In addition, ongoing advice and representation on pharmaceutical advertising law.

  • Ongoing advice to Amicus Therapeutics GmbH on approval and contract law, on clinical studies and cooperation agreements with medical centers, on sales and advertising law as well as on compliance; recently also provided advice and representation in connection with AMNOG proceedings in price negotiations on reimbursement contributions with the National Association of Statutory Health Insurance Funds following the extension of approval for medicinal products; also advice on benefit assessment matters with the Federal Joint Committee.

Möhrle Happ Luther

Möhrle Happ Luther's life sciences team focuses on pharmaceutical and pharmaceutical advertising law advice – Julia Luther is a key contact here – as well as on AMNOG proceedings, market access, reimbursement issues and compliance, which are key strengths of Henning Anders. The practice is regularly instructed by pharmaceutical companies, medical device and digital healthcare app manufacturers, hospitals, medical care centers and medical facilities. Joachim Jung is experienced in supporting digitisation projects.

Weitere Kernanwälte:

Henning Anders; Julia Luther; Joachim Jung


Referenzen

‘Henning Anders has excellent knowledge of the life sciences/pharma sector.’

‘The personal nature, always cheerful and cheerful, always 150% spot-on and no matter how tight the deadlines are, MHL always has a suggested solution.’

‘Julia Luther’s team offers very thorough, reliable legal advice that is closely tailored to the needs of the client.’

‘Working with the team’s lawyers is uncomplicated, solution-oriented and always a pleasure.’

‘Great team with many different skills. This applies to all areas and the entire team. You get quick feedback at any time.’

‘Pragmatic and legally high-quality feedback/assessments within a short time.’

‘Quick accessibility, pragmatic approaches to solutions, solution-oriented.’

‘Many years of experience with competition law disputes in the pharmaceutical sector. Very good commitment to the interests of the client. Fast and efficient work. Clear and comprehensible recommendations and decision support.’

Kernmandanten

Almirall Hermal GmbH


Amgen GmbH


AstraZeneca GmbH


Pfizer Pharma GmbH/ Pfizer Deutschland GmbH/


Novartis Pharma GmbH


Highlight-Mandate


  • Ongoing advice to AstraZeneca GmbH on, among other things, advertising campaigns, healthcare compliance, digital projects; here in particular on digital marketing and regulatory issues in connection with the integration of medical apps. Additionally, representation in litigation in the areas of diabetes, heart disease, renal insufficiency, asthma, COPD and oncology.

  • Advising Amgen GmbH on questions relating to pharmaceutical advertising law, including support in out-of-court and contentious disputes.

  • Advising Pfizer Pharma GmbH on pharmaceutical advertising law, particularly in the area of ​​vaccines, as well as trademark law support, including in-court and out-of-court support.

Oppenländer Rechtsanwälte

Led by Timo Kieser, Christina Koppe-Zagouras and Katharina Köbler, Oppenländer Rechtsanwälte's team focuses on the areas pharmaceuticals, pharmacies and medical devices. The team assists with regulatory issues and proceedings before the authorities as well as labeling and marketing-related matters pertaining to competition, pharmaceutical advertising and distribution law. A recent focus was on digitisation matters in the healthcare sector as well as regulatory issues in connection with medicinal cannabis. The practice frequently assists with contentious proceedings in the pharmacy sector.

Praxisleiter:

Timo Kieser; Katharina Köbler; Christina Koppe-Zagouras


Referenzen

‘Dr. Katharina Köbler: Very fast response times, practical solution suggestions, extreme clarity even on complex topics, communicates the topics in an understandable manner,  focuses and limits herself excellently to what is necessary.’

Kernmandanten

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG


WEPA Apothekenbedarf GmbH & Co. KG


Optica


PHAGRO Bundesverband des pharmazeutischen Großhandels e.V.


Reckitt Benckiser Deutschland GmbH


Accord Healthcare GmbH


Accord Healthcare Ltd. (UK)


Accord Healthcare Ltd.


Accord Healthcare S.L.U.


Andreas Hettich GmbH & Co. KG


Herbert Waldmann GmbH & Co. KG


Biologische Heilmittel Heel GmbH


Metronomia Holding UGHMD Services GmbH


Intas Third Party Sales 2005 S.L.U. (INTAS B2B)


Dr. Falk Pharma GmbH


Bioloving Germany Biotech GmbH & Co. KG


Vapotherm Inc.IFA GmbH


KLINGEL medical metal GmbH


Highlight-Mandate


  • Ongoing advice to Accord HealthCare Ltd. and Accord Healthcare GmbH on all procurement, antitrust and pharmaceutical law issues in connection with discount contract tenders from all major health insurance companies.

  • Advice on pharmaceutical and medicinal products law to GlaxoSmithKline Consumer Healthcare GmbH & Co. KG; Recently, support in a dispute with competitors regarding, among other things, OTC preparations.

  • Supporting IFA GmbH in the procurement and social security law statement on the calculation of manufacturer discounts in accordance with Section 131 Paragraph 4 SGB V. The statement concerns questions in the area of ​​contract awarding in the social insurance and health sector as well as the interaction of association agreements and legal regulations.

Osborne Clarke

Osborne Clarke's team routinely advises on IP law issues in patent infringement proceedings, while the regulatory expertise is called upon in matters pertaining to pharmaceutical advertising law. This is complemented by capacities at the corporate law interface, such as the advice on pharmaceutical cooperation and licensing agreements, including cross-border transactions, as well as experience in supporting digitisation projects. The project work frequently pertains to patient care and treatment in connection with healthcare platforms. AI-related topics in the medical device segment and related data protection issues are also covered, practice head Tim Reinhard is a key contact here.

Praxisleiter:

Tim Reinhard


Weitere Kernanwälte:

Andrea Schmoll; Flemming Moos; Fabian Christoph


Referenzen

‘Andrea Schmoll: Very pleasant in management matters, is very aware of the specialist knowledge in her team as well as in the firm and actively involves relevant colleagues to ensure consistently high quality.’

‘Dedicated team that works well with new inquiries.’

Kernmandanten

Bruker Gruppe Deutschland (Bruker EAS, Bruker HTS, Bruker BioSpin, RI Research)


CEVEC Pharmaceuticals GmbH


Fresenius SE


Gerresheimer AG


Haema AG


PharmaDrug, Inc.


VAMED Rehazentren Deutschland GmbH


Grifols Deutschland GmbH


Highlight-Mandate


  • Advice and support for the Bruker Group Germany on various projects, including dismissal protection procedures, realignment of the BASC division and design and implementation of a new working time and time recording system.

  • Supporting Fresenius SE in the planning and implementation of a project to convert any active contractual relationships based on the old EU standard contractual clauses to the new EU standard contractual clauses.

  • Advising PharmaDrug, Inc. on the sale of all shares of its German subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp.

Preu Bohlig & Partner

Preu Bohlig & Partner specialises in pharmaceutical, competition and cosmetics law and routinely advises pharmaceutical and medical device companies on issues pertaining to the licensing, development and marketing of pharmaceuticals. This offering is complemented by Daniel Hoppe's patent law expertise as well as Alexander Meier's experience in product liability and life sciences compliance; Meier is also experienced in the area of ​​orphan drugs. Both are key contacts of the practice led by Peter von Czettritz; von Czettritz is well versed in third-party opposition proceedings.

Praxisleiter:

Peter von Czettritz


Weitere Kernanwälte:

Alexander Meier; Daniel Hoppe; Tanja Strelow


Referenzen

‘Peter von Czettritz: Expertise and experience in pharmaceutical and medical device law.’

Kernmandanten

Moderna Therapeutics, Inc.


Formycon AG


LFB Laboratoire Francais du Fractionnement et Biotechnologies SA


MIT Gesundheit GmbH


Highlight-Mandate


Raue

Raue's Berlin-based team is jointly led by Katharina Wodarz (transaction support, physician contract law, pharmaceutical pricing and pharmacy law, contentious proceedings before authorities and courts) and Maren Bedau (hospital sector, physician contract law, nursing care companies, compliance). Former practice head Wolfgang Kuhla moved to of counsel status (he continues to advise on planning and financing issues as well as on the drafting of cooperation agreements and physicians' contracts). The team focuses on regulatory advice and transaction support, which benefits investors, start-ups, hospitals, medical care centers, pharmaceutical and medical device companies and mail order pharmacies. The transaction capacities were strengthened with the addition of Nadine Hartung from McDermott Will & Emery Rechtsanwälte Steuerberater LLP in March 2023. Thanks to cross-practice cooperation, various interfacing matters, including IP, employment and competition law are also covered.

Praxisleiter:

Maren Bedau; Katharina Wodarz


Weitere Kernanwälte:

Nadine Hartung; Wolfgang Kuhla


Referenzen

‘Maren Bedau: Excellent availability and communication. Speed ​​in the projects and absolute specialist knowledge.’

‘Raue has extensive experience in supporting setting up medical care centers. They maintain good relationships with the committees of the statutory health insurance self-administration, which enables regulatory questions to be clarified at an early stage of the project and leads to the smoothest possible process.’

‘The law firm combines the highest legal quality with pragmatic solutions and fast response times.’

‘Dr. Maren Bedau: Excellent competence in general and specific questions of medical and social law. Outstanding, clear communication, high availability and extraordinary commitment.’

‘Dr. Katharina Wodarz: Solution-oriented and reliable.’

Kernmandanten

DocMorris NV


ALM


Landkreis Trier Saarburg


Doktor.de


Years


Kirinus Health


DRK Kliniken Berlin


Schön Klinik SE


Kliniken Nordoberpfalz AG


Proteopath GmbH


Labor Berlin


Sonic Healthcare Germany


Deutsches Herzzentrum Berlin (DHZB)


Omnicare


Eterno Health


DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH


Johanniter-Krankenhaus Treuenbrietzen


Advita Pflegedienst GmbH


MIA Medical Information Analytics GmbH


Sanofi-Aventis Deutschland GmbH


Highlight-Mandate


  • Representation of DocMorris NV in landmark proceedings regarding the admissibility of online marketplaces for pharmacy products.

  • Advising Sanofi on the market launch of DiGas, including cost reimbursement.

  • Representation of the DRK Kliniken Berlin Köpenick in a model lawsuit against the state of Berlin. The proceedings are directed against the co-financing of municipal hospitals from the state budget, which, from the perspective of Berlin’s 29 hospital operators, distorts competition.

DLA Piper

DLA Piper 's life sciences practice follows a cross-location and cross-sector approach, thus routinely advises on large-scale transactions in the healthcare sector. Patent litigator Philipp Cepl and Kokularajah Paheenthararajah (patent and license litigation) jointly head the team; the latter is also a qualified physician and joined the partner roster at the same time as Moritz von Hesberg (M&A) in May 2023. The team focuses on transaction support, patent law and interfacing regulatory matters, including the advertising and marketing of medical devices, market access and compliance as well as research agreements. EU regulatory issues are handled thanks to the cooperation with the EU life sciences regulatory practice, which launched in February 2023. Digital healthcare matters are covered thanks to the cooperation with the data protection and IT team.

Praxisleiter:

Kokularajah Paheenthararajah; Philipp Cepl


Weitere Kernanwälte:

Thilo Streit; Moritz von Hesberg


Kernmandanten

ResMed


Highlight-Mandate


  • Advising ResMed on the acquisition of MEDIFOX DAN, a leading German provider of software solutions for out-of-hospital care, from HgCapital, a private equity investor in the technology and services sector.

Ehlers, Ehlers & Partner

Ehlers, Ehlers & Partner specialises in medical law and impresses with its expertise in AMNOG and legislative proceedings. Other competencies include the advice on market access, product development and compliance issues as well as issues at the digitisation interface; the latter includes telematics, data protection, digital medical devices and digital healthcare services. Among the client roster are pharmaceutical companies and medical device manufacturers, which also benefit from the team's experience in restructuring and transactions. The practice is led by medical lawyer Alexander Ehlers and Christian Rybak, who is regularly instructed by US-based clients.

Praxisleiter:

Alexander Ehlers; Christian Rybak


Weitere Kernanwälte:

Julian Bartholomä


Referenzen

‘An exceptional team.’

‘Christian Rybak: An absolute expert on all health policy and legal issues with an incomparable network at the political levels and with all important stakeholders in the healthcare system in Berlin.’

‘Diverse team, always well informed, oriented towards solutions.’

‘Alexander Ehlers: Good leader, charming, excellently connected.’

‘Christian Rybak: Excellently informed, good conversationalist, committed and ready to work.’

‘Julian Bartholomä: Excellent lawyer with vision and good understanding of the market. Excellently networked.’

‘Combination of legal expertise with a business strategic focus.’

Kernmandanten

Bundesministerium für Gesundheit


CKM Shared Services GmbH


CSL Behring


CytoSorbents Europe


Eurozyto


Ipsen


Jazz Pharmaceuticals


LEO Pharma


Haemonetics Corporation


MSH Europe


ResMed


LeMaitre Vascular, Inc.


Reaction Biology Corporation


UPD


Highlight-Mandate


  • Advising a pharmaceutical company on the implementation of new reimbursement options.

  • Advising a MedTec company on the takeover of a competitor.

Fieldfisher

Fieldfisher advises pharmaceutical, biotechnology and medical technology companies, healthcare providers and medical technology start-ups on regulatory market entry for medical devices and pharmaceuticals, including related clinical trials, conformity assessment procedures and licensing issues, as well as on compliance and transactions. This mirrors the focus of practice head Cord Willhöft.

Praxisleiter:

Cord Willhöft


Referenzen

‘Excellent lawyers, who respond to the needs of customers and always find the right solution. Diverse dedicated teams that also offer a good balance of partners and associates.’

‘Cord Willhöft: Proven expert in the life sciences sector; experienced, precise, pragmatic.’

Kernmandanten

Asahi Kasei Bioprocess


Butterfly Networks, Inc.


Corvia Medical


Galvanize Therapeutics


Ideaya Biosciences


Jena Valve


Medicaroid GmbH


Priocept BioRobotics Inc.


Procept BioRobotics Inc.


Pulmonx Sarl und Pulmonx Co.


ResMed GmbH & Co KG


Starkey Inc.


ZOLL CMS GmbH und ZOLL Medical Corporation


Highlight-Mandate


  • Advising Pulmonx Sarl and Pulmonx Co on market access, healthcare compliance and sales as well as regulatory issues.

  • General legal advice to ResMed GmbH & Co KG as well as advice on transactions and real estate.

  • Legal and strategic advice to ZOLL CMS GmbH and ZOLL Medical Corporation on reimbursement of medical aids, healthcare compliance, contract drafting and data protection (GDPR).

GÖRG Partnerschaft von Rechtsanwälten mbB

GÖRG Partnerschaft von Rechtsanwälten mbB advises on pharmacy, pharmaceutical, medical device and hospital law and is regularly instructed by health insurance companies, private and public clinics, nursing care facilities, pharmacies, medical device manufacturers and investors. The regulatory segment is led by co-head Marc Schüffner (Berlin), while co-head John-Patrick Bischoff (Hamburg) is well versed in healthcare-related transactions. The latter area was further strengthened with the arrival of Markus Söhnchen in August 2023 (previously co-practice head at GSK Stockmann). The interdisciplinary approach also covers interfacing real estate, corporate, procurement, IP and employment law matters.

Praxisleiter:

Marc Schüffner; John-Patrick Bischoff


Weitere Kernanwälte:

Katja Kuck; Markus Söhnchen


Referenzen

‘Very strong combined knowledge of corporate and medical law.’

‘Easy accessibility of the partners combined with a high level of competence and flexibility in difficult legal questions.’

‘Absolutely error-free work, great care and excellent adherence to deadlines.’

‘Excellent professional team that works together excellently and coordinates excellently in the interests of the client. Direct partner support avoids inefficiencies and issues are dealt with extremely efficiently.’

‘Very good, committed team. Friendly, approachable and rather amicable and yet serious and well-founded.’

‘A team with role model character.’

Kernmandanten

amedes Medizinische Dienstleistungen GmbH


Carl-Thiem-Klinikum Cottbus gGmbH


Endoprothesenregister Deutschland GmbH


Gemeinsamer Bundesausschuss


Heidekreis-Klinikum gGmbH


Heidelberg Pharma AG


Hologic-Gruppe


Insulet Corporation


Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit (LAVG) des Landes Brandenburg


Livica GmbH


Main-Kinzig-Kreis (MKK)


Morphosys AG


Oberbergkliniken


PubliCare GmbH


Rentschler Biopharma SE


Schmerzzentrum Berlin / Schmerzklinik Berlin


SCPI Pierval Santé


SMH Schnelle medizinische Hilfe GmbH


TERTIANUM Seniorenresidenzen/DPF AG


Ufenau Capital Partners AG


UKSH Universitätsklinikum Schleswig-Holstein AöR


Highlight-Mandate


  • Advising amedes on the acquisition of  general medical practices in Germany.

  • Advising the Oberbergkliniken on project developments, particularly in health law, tenancy law, labor law as well as various compliance and medical law topics.

  • Advising Ufenau Capital Partners on the restructuring of the shareholder relationships of the Altano Group and the Corius Group.

GSK Stockmann

GSK Stockmann team is led by Maritheres Palichleb, who specialises in supporting national and international institutional investors in nursing care real estate investments and transactions as well as VC investments in start-ups in the healthcare, biotechnology and medical technology sectors. Former co-head Markus Söhnchen (corporate and M&A) joined GÖRG Partnerschaft von Rechtsanwälten mbB in August 2023. Other competencies include the advice on compliance, including matters pertaining to the Hospital Future Act, such as the modernisation of hospitals, digital infrastructure and safeguarding of emergency capacities.

Praxisleiter:

Maritheres Palichleb


Referenzen

‘Very good, strong team both professionally and personally.’

Kernmandanten

DLE Living GmbH


ENDRA Life Sciences Inc.


G. Pohl-Boskamp GmbH & Co. KG


Haemonetics GmbH


Integra LifeSciences Corporation


Medraxa Terhapeutics GmbH


Primonial REIM Germany AG


Vetter Pharma-Fertigung GmbH & Co. KG


WELL Health Ventures Inc., Horizons Ventures


Highlight-Mandate


  • Advising Medraxa Terhapeutics GmbH on CMS structure and business partner due diligence.

  • Ongoing advice to DLE Living GmbH on the acquisition of nursing care properties, including corporate law and tax transaction structuring of asset deals and share deals, due diligence, purchase agreement, financing.

  • Advising Target Global on a follow-up round of financing for the Berlin company Patient 21.

Harmsen Utescher

Harmsen Utescher specialises in IP law and routinely assists with healthcare-related patent litigation and pharmaceutical advertising issues, as well as interfacing pharmaceutical, food and cosmetics law matters, including parallel imports and product launches. Practice head Rainer Kaase boasts similar competencies and regularly assists with contentious matters before German and European courts. The client roster includes pharmaceutical companies and medical device manufacturers.

Praxisleiter:

Rainer Kaase


Weitere Kernanwälte:

Andrea Marx


Kernmandanten

STADA


Astellas


Neubourg Skin Care


Highlight-Mandate


  • Advising STADA and various group companies on the areas of HWG, parallel imports, soft IP, IP transactions and M&A.

  • Advising Neubourg Skin Care on the area of pharmaceutical advertising law as well as on the areas of pharmaceuticals/medical devices/cosmetics; also assistance with new product launches.

  • Representation of Astellas Pharma in pharmaceutical advertising proceedings.

michels.pmks Rechtsanwälte

Cologne-based michels.pmks Rechtsanwälte impresses with medical law expertise, which is called upon by hospitals, medical care centers, medical practices and healthcare companies. Kerrin Schillhorn focuses on the inpatient care area and jointly heads the practice with Jens-Peter Jahn, who primarily advises on outpatient care facilities. Matters at the interface between medical and employment law are handled by Jannis Kamann and Marcus Michels.

Praxisleiter:

Kerrin Schillhorn; Jens-Peter Jahn


Weitere Kernanwälte:

Jannis Kamann; Marcus Michels


Referenzen

‘Dr. Kerrin Schillhorn is very experienced, always up to date legally and absolutely reliable.’

‘Jens-Peter Jahn is a proven expert in physician contract law and (dental) medical corporate law with the highest level of competence and experience. The same applies without reservation to Dr. Kerrin Schillhorn in the area of ​​hospital law.’

‘Really available at any time. Highly competent, best networking at the administrative levels and therefore pragmatic and excellent solutions.’

‘Deep into the subject matter. Fastest solutions.’

‘Jens-Peter Jahn: Reliable, experienced, good.’

‘Available at any time, friendly and competent. Good and well-managed substitute situations. All skills available and good network drawing on external skills.’

‘I was able to gain experience with several specialist lawyers from michels.pmks. I felt like I was in very good hands and received excellent advice from every single one of them.’

‘Miss Dr. Kerrin Schillhorn has excellent expertise in all topics relevant to hospital planning.’

Kernmandanten

Katholische Hospitalvereinigung Weser-Egge gGmbH


Krankenhaus Porz am Rhein GmbH


Kreisklinikum Siegen GmbH


Marien Gesellschaft Siegen gGmbH


MVZ am St. Marien-Hospital Friesoythe gGmbH


MVZ Med Center GmbH Siegen


MVZ des Universitätsklinikums Köln gGmbH


MVZ St. Marien GmbH


St. Franziskus-Stiftung Münster


St. Vinzenz Krankenhaus GmbH Köln


Universitätsklinikum Köln AöR


Vestische Caritas-Kliniken gGmbH


Highlight-Mandate


  • Advice on hospital law and representation of the Catholic Hospital Association Weser-Egge gGmbH with regard to cooperation with branches and other service providers as well as support in hospital planning.

  • Advice on physician contract law and representation of the medical care center of the University Hospital of Cologne gGmbH before the admissions and appointment committee as well as the KV.

  • Strategic hospital law advice to the St. Franziskus Foundation and its 15 hospitals with over 4,000 beds, including hospital planning, basic questions, organizational requirements for hospitals as well as advice on structural audits according to StrOPS-RL.

Noerr

Noerr's practice closely cooperates with the M&A team and frequently assists with transactions pertaining to nursing care facilities, hospitals, medical care centers and medical devices. The team offers further cross-practice capacities in the digital healthcare segment, where expertise in digital commerce and life sciences matters is combined. The practice is led by food law specialist Evelyn Schulz; she is supported by Susann Jahn, who is experienced in regulatory matters and joined the partner roster in early 2023.

Praxisleiter:

Evelyn Schulz


Weitere Kernanwälte:

Susann Jahn


Kernmandanten

Ada Health


Advokatfirman Vinge


Aponeo


Arrow Generics


Bayer


BonelliErede


Butler Snow


Carl Zeiss


Casa Verde Capital


Cellex-Gruppe


Cerner Corporation


Debeka Krankenversicherung


Doctor mi! GmbH


DRK Kliniken Nordhessen


Ergon Capital Partners


Europäische Investitionsbank


Fraunhofer-Gesellschaft


Fresenius Medical Care


GWT-TUD GmbH


Helios Kliniken GmbH


Hera Residenzen Pflege


Home Shopping Europe GmbH


ICON PLC


Laureus Capital


LFB


LOGEX


Loyens & Loeff


M4Capital


New Flag


Omnicare


Procter & Gamble


Qualitätssicherungs-Initiative Pathologie QuIP


Regeneron Pharmaceuticals Inc


Stada Arzneimittel AG


Wacker Biotech


Wir für Gesundheit


Highlight-Mandate


  • Advising Ada Health on medical device law and data protection issues.

  • Advising a leading generic drug manufacturer on the defense of antitrust claims for damages following the European Commission’s fine decision in Lundbeck due to an alleged delay in placing a generic drug on the market.

  • Advising the Else Kröner-Fresenius Foundation on the ongoing reorganization of the Fresenius Group.

Oppenhoff

Oppenhoff's interdisciplinary team advises pharmaceutical manufacturers, biotechnology companies, hospitals, nursing homes, health insurance companies and care providers on day-to-day business operations and also focuses on M&A transactions and venture capital investments. Co-practice head Gabriele Fontane covers the corporate, M&A and private equity interface and jointly heads the team with Peter Klappich, who is a key contact for litigation and arbitration and also advises on regulatory, competition and commercial law. This is complemented by expertise in the medicinal cannabis segment, where the team recently assisted with the cross-border negotiations of supply contracts as well as the regulatory advice on related import and export issues.

Praxisleiter:

Gabriele Fontane; Peter Klappich


Weitere Kernanwälte:

Jürgen Hartung


Kernmandanten

Aphria Inc.


Dr. August Wolff GmbH & Co. KG Arzneimittel


LR Health & Beauty Bristol-Myers Squibb GmbH & Co. KGaA


Johnson & Johnson GmbH


Evonik Industries AG


Shop Apotheke Europe N.V.


CC Pharma GmbH


Ecolog Deutschland GmbH


CNP Pharma


Highlight-Mandate


  • Expert opinion for Johnson & Johnson in connection with the permissibility of the use of medical data.

  • Representation of several doctors in the sale of Nephrologicum Westfalen, one of the largest independent providers of nephrology and dialysis care services in North Rhine-Westphalia, to the financial investor Adiuva.

PPP Rechtsanwälte

PPP Rechtsanwälte specialises in the healthcare sector and covers all aspects of medical and health law in the outpatient and inpatient segments and complements this with expertise in employment, social security, data protection and tax law. The team is regularly instructed by healthcare institutions on the entire value chain, including formation and licensing,  M&A, restructuring and litigation. The team is led by Andreas Penner , Tanja Koopmann-Röckendorf and André Bohmeier in Düsseldorf, Ute Pittrof in Ingolstadt, Felix Reimer in Heilbronn and Matthias Wallhäuser in Bergisch Gladbach. Hospital and tax law specialist Benjamin Liedy (previously at Schick und Schaudt Rechtsanwälte ) joined the  newly established Tübingen location in May 2023; Claudia Mareck advises service providers on hospital and physician contract law as well as e-health matters and joined the team in January 2024 from KMH Medizinrecht.

Praxisleiter:

Andreas Penner; Felix Reimer; Ute Pittrof; Matthias Wallhäuser; Benjamin Liedy; Tanja Koopmann-Röckendorf; André Bohmeier


Weitere Kernanwälte:

Claudia Mareck


Kernmandanten

Krankenhausweckverband Rheinland


Sikomed Unternehmensberatung Göttingen


KMG Kliniken SE


CTL


Bergisches Zentrum Kardiologie Angiologie


Highlight-Mandate


  • Supporting a client in the constitutional complaint against the decision of the Federal Social Court of January 24, 2023 (B 1 KR 7/22 R) pertaining to the so-called Nikolausbeschluss.

  • Supporting Ategris, Rehanova and the Rhein-Neuss-Kliniken in the development of a catalog of criteria for the nationwide updating of hospital planning in North Rhine-Westphalia.

  • Advising KMG Kliniken SE on restructuring in hospital care through concentration, closure and relocation in several federal states.

Schmidt, von der Osten & Huber

Schmidt, von der Osten & Huber is experienced in hospital law and also advises medical and non-medical service providers, investors, start-ups and health insurance companies on all issues of medical and health law. The team also covers the corporate and employment law interfaces, including transactions and regulatory matters.

Weitere Kernanwälte:

Franz-Josef Dahm; Roland Flasbarth; Corinna Schmidt-Murra; Stefan Bäune; Regine Cramer


Kernmandanten

aescoLOGIC


Alfried Krupp Krankenhaus


Bundesverband der Knappschaftsärzte e.V.


Dr. August Wolff GmbH & Co. KG


Fresenius Medical Care


IMEX Dental Gruppe


Klinikum Dortmund gGmbH


KlinikumStadtSoest gGmbH


Lohmann & Rauscher


Universitätsklinikum Essen


Universitätsklinikum Jena


Urban Technology (DrSmile)


Highlight-Mandate


Tsambikakis & Partner Rechtsanwälte

Tsambikakis & Partner Rechtsanwälte is experienced in advising hospitals, doctors, pharmaceutical and medical device manufacturers on medical criminal law matters, including investigations and criminal proceedings, as well as compliance matters. The team is jointly led by the commercial, tax and medical criminal law specialist Michael Tsambikakis and the medical law and compliance expert Daniela Etterer. Karolina Kessler, who is also experienced in medical and white-collar criminal law, joined the partner roster in early 2023.

Praxisleiter:

Michael Tsambikakis; Daniela Etterer


Weitere Kernanwälte:

Karolina Kessler


Referenzen

‘Highly specialized, reliable.’

‘Daniela Etterer: Fast response and practical advice.’

Kernmandanten

Bundesministerium für Gesundheit


Highlight-Mandate


  • Advising the management and the supervisory board on the implementation of compliance for the supervisory board in a healthcare group.

  • Corporate representation of a large hospital operator in an investigation into breach of trust and fraud.

  • Support in implementing and operating a whistleblower system in anticipation of the Whistleblower Protection Act for the Federal Ministry of Health.

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB is experienced in pharmaceutical law with a focus on pharmaceutical advertising law. The team is well versed in the enforcement of claims in interim injunction proceedings pertaining to pharmaceuticals, medical devices and cosmetics. Claudia Böhm regularly represents clients in pharmaceutical advertising law proceedings and is experienced in the vaccines segment. Anselm Brandi-Dohrn is a key contact for contract drafting, including license and cooperation agreements.

Weitere Kernanwälte:

Claudia Böhm; Anselm Brandi-Dohrn; Holger Alt


Kernmandanten

Aceto GmbH


Acino-Gruppe


Bavarian Nordic GmbH


Belano Medical AG


Betterguards GmbH


CellAct Pharma GmbH


Cellbricks GmbH


EVER Neuro Pharma GmbH (AT); EVER Pharma GmbH (DE); EVER Valinject GmbH (DE)


Gilead Sciences GmbH


LEO Pharma GmbH


Lipotype GmbH


Madaus & Lauscher GmbH


Nekonal S.a.r.l. (Lux)


Sanochemia Pharmazeutika GmbH


Sedana Medical AB (publ)


Highlight-Mandate


  • Advising and representing the EVER Group in setting up pharmaceutical production for drugs and medical devices at locations at home and abroad.

  • Advising Gilead Sciences GmbH in competition law disputes with ViiV Healthcare GmbH regarding new scientific data.

WilmerHale

WilmerHale's team is led by Hans-Georg Kamann and focuses on regulatory issues pertaining to the pharmaceutical sector and medical devices. Kamann and Peter Gey regularly join forces in contentious proceedings for pharmaceutical and medical device companies as well as associations. Both act from Frankfurt and Brussels and advise at the interfaces with antitrust, competition and EU law. Martin Braun has data protection expertise and advises on product approvals and data transfers as well as clinical studies.

Praxisleiter:

Hans-Georg Kamann


Weitere Kernanwälte:

Peter Gey; Martin Braun


Kernmandanten

Becton Dickinson GmbH


Bundesverband der Pharmazeutischen Industrie (BPI)


Deutsches Hörgeräte Institut GmbH


Medtronic, Inc


Highlight-Mandate


  • Advising Becton Dickinson on, among other things, issues of competition, product liability and distribution law, including advising on disputes relating to advertising for medical devices as well as advising on procurement law issues and contract and antitrust law.

  • Advice and reports on the MDR certification of the Deutsches Hörgeräte Institut GmbH as an independent testing laboratory in accordance with Section 18 MPDG.

  • Successful defense of Medtronic in an IP litigation regarding a new product.